ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

138
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Refresh
31 Aug 2020 15:01

Asia HY Trade Recommendations - August 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of August includes a summary of our recommendations, as well as our high-conviction ideas....

Logo
249 Views
Share
19 Aug 2020 16:15

Glenmark Pharmaceuticals - Earnings Flash - Q1 FY 2020-21 Results - Lucror Analytics

Glenmark Pharmaceuticals' Q1/20-21 results were better than expected, despite muted revenue growth amid the COVID-19 pandemic. The company...

Logo
285 Views
Share
bearishPvr Inox
08 Aug 2020 22:43

Forensic Accounting | High Risk Companies in India

As promised at Smartkarma Webinar | Accounting and Insider Diagnostics, we have extended our forensic analysis model to India. To learn more about...

Logo
513 Views
Share
05 Aug 2020 15:54

Asia HY Monthly - LARA And Credit Bias Study (2020 Update) - Lucror Analytics

In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments for companies under our coverage over the past few years,...

Logo
344 Views
Share
03 Aug 2020 00:19

Parkway Pantai: Good Brand with Limited Upside

We initiate our coverage of Parkway Pantai Ltd (0794727D SP) (Parkway Pantai), a wholly-owned subsidiary of IHH Healthcare (IHH MK) of which major...

Logo
392 Views
Share
x